These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21089349)

  • 1. [Novel catabolic pathway of glycosphingolipids that includes a cytosolic glucocerebrosidase, klotho-related protein (KLrP)].
    Hayashi Y; Okino N; Kakuta Y; Ito M
    Tanpakushitsu Kakusan Koso; 2008 Sep; 53(12 Suppl):1462-7. PubMed ID: 21089349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Novel metabolic pathway of glucosylceramide that involves Klotho-related protein KLrP].
    Hayashi Y; Okino N; Ito M
    Seikagaku; 2010 Jan; 82(1):47-53. PubMed ID: 20169998
    [No Abstract]   [Full Text] [Related]  

  • 3. Klotho-Related Protein KLrP: Structure and Functions.
    Hayashi Y; Ito M
    Vitam Horm; 2016; 101():1-16. PubMed ID: 27125736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho-related protein is a novel cytosolic neutral beta-glycosylceramidase.
    Hayashi Y; Okino N; Kakuta Y; Shikanai T; Tani M; Narimatsu H; Ito M
    J Biol Chem; 2007 Oct; 282(42):30889-900. PubMed ID: 17595169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease.
    Sinclair GB; Jevon G; Colobong KE; Randall DR; Choy FY; Clarke LA
    Mol Genet Metab; 2007 Feb; 90(2):148-56. PubMed ID: 17079175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S; López-Viñas E; Gómez-Puertas P; Chabás A; Vilageliu L; Grinberg D
    Proteins; 2008 Feb; 70(3):882-91. PubMed ID: 17803231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of glucocerebrosidase and the treatment of Gaucher disease.
    Barranger JA; Tomich J; Weiler S; Sakallah S; Sansieri C; Mifflin T; Bahnson A; Wei FS; Wei JF; Vallor M
    Cytokines Mol Ther; 1995 Sep; 1(3):149-63. PubMed ID: 9384672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat brain cytosol protein which accelerates the translocation of galactosylceramide, lactosylceramide and glucosylceramide between membranes.
    Yamada K; Sasaki T
    Biochim Biophys Acta; 1982 May; 687(2):195-203. PubMed ID: 7093250
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease.
    Karageorgos L; Hein L; Rozaklis T; Adams M; Duplock S; Snel M; Hemsley K; Kuchel T; Smith N; Hopwood JJ
    Neurobiol Dis; 2016 Jul; 91():143-54. PubMed ID: 26976737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebroside storage in normal monocyte cultures.
    Hardy B; Teitelman-Weissman B; Chazan S; Neri A
    Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell biology: taxi service for lipids.
    Futerman AH
    Nature; 2007 Sep; 449(7158):35-7. PubMed ID: 17805285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preclinical research of a new therapy for Gaucher's disease with F213I mutation].
    Hou L; Kousaku O
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):381-4. PubMed ID: 14556188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors and stimulators of glucocerebroside metabolism.
    Radin NS
    Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
    [No Abstract]   [Full Text] [Related]  

  • 15. L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.
    Gal AE; Pentchev PG; Massey JM; Brady RO
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3083-6. PubMed ID: 290986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.
    Midorikawa M; Okada S; Yutaka T; Yabuuchi H; Naoi M; Kiuchi K; Yagi K
    Biochem Int; 1985 Sep; 11(3):327-32. PubMed ID: 4062951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
    Choy FY; Wei C; Levin D
    Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.
    Ron I; Horowitz M
    Hum Mol Genet; 2005 Aug; 14(16):2387-98. PubMed ID: 16000318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of human glucocerebrosidase from stable transformed insect cells using native signal sequences.
    Sinclair G; Pfeifer TA; Grigliatti TA; Choy FY
    Biochem Cell Biol; 2006 Apr; 84(2):148-56. PubMed ID: 16609695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.